Get access to our best features
Get access to our best features
Published

Scribe Therapeutics becomes latest CRISPR company to announce layoffs

Summary by STAT
Co-founded by Jennifer Doudna, Scribe will lose 20% of its staff as it moves toward clinical trials with its CasX gene editor.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics